Terminologies de Santé
1.5.0 - final-text France flag

Terminologies de Santé - version de développement local (v1.5.0) construite par les outils de publication FHIR (HL7® FHIR® Standard). Voir le répertoire des versions publiées

CodeSystem: Substance Admin Substitution

Official URL: http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution Version: 3.0.0
Active as of 2019-03-20 Responsible: Health Level Seven International Computable Name: SubstanceAdminSubstitution
Other Identifiers: OID:2.16.840.1.113883.5.1070

Copyright/Legal: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html

Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.

Cette terminologie de référence (CodeSystem) est référencé dans la définition de contenu des jeux de valeurs (ValueSet) suivants :

version : 1; Dernière mise à jour : 2026-01-07 10:12:52+0100; Langue : en

Propriétés

Cette terminologie de référence (CodeSystem) définit les propriétés suivantes pour ses concepts

NomCodeURITypeDescription
internalId internalId http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id code The internal identifier for the concept in the HL7 Access database repository.
Not Selectable notSelectable http://hl7.org/fhir/concept-properties#notSelectable boolean Indicates that the code is abstract - only intended to be used as a selector for other concepts
status status http://hl7.org/fhir/concept-properties#status code Designation of a concept's state. Normally is not populated unless the state is retired.

Concepts

This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution defines the following codes dans une hiérarchie Is-A:

NivCodeAffichageDéfinitioninternalIdNot Selectablestatus
1 _ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode

Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

 21284 true active
2   E equivalent

Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

 23107 active
3     EC equivalent composition

Substitution occurred or is permitted with another product that is a:

  • pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
  • pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

  • Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
  • Pharmaceutical equivalent: Lisonpril for Zestril
 23108 active
4       BC brand composition

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven
 23109 active
4       G generic composition

Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
 16623 active
3     TE therapeutic alternative

Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

  • ranitidine for Tagamet
 16624 active
4       TB therapeutic brand

Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet
 23105 active
4       TG therapeutic generic

Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine
 23106 active
2   F formulary

This substitution was performed or is permitted based on formulary guidelines.

 16625 active
2   N none

No substitution occurred or is permitted.

 16622 active